中国医师协会检验医师分会心血管专家委员会.B型利钠肽及N末端B型利钠肽前体实验室检测与临床应用中国专家共识[J].中华医学杂志,2022(35).

王帅,赵志强,王贤良,阎小妍,钟成梁,尚美霞,王聪,林姗姗,胡思源,毛静远,张伯礼.芪参益气滴丸治疗缺血性心力衰竭的多中心、前瞻性队列研究[J].中医杂志,2022(07).

陈日锦,江玲,王晓玉.芪参益气滴丸联合沙库巴曲缬沙坦治疗高龄射血分数保留心力衰竭的疗效观察[J].心血管病防治知识,2021(10).

Working Group on Heart Failure, National Center for Cardiovascular Quality Improvement(NCCQI).2020中国心力衰竭医疗质量控制报告[J].中国循环杂志,2021(03).

National Center for Gerontology National Clinical Research Center for Geriatric Disorders,Cardiovascular Branch of Chinese Geriatrics Society,Beijing Medical Association Imaging Group of Cardiovascular Department.中国成人心力衰竭超声心动图规范化检查专家共识[J].中国循环杂志,2019(05).

王华,梁延春.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018(10).

刘岳,汪芳.沙库巴曲缬沙坦的药代动力学和药效学特点[J].中国循环杂志,2018(02).

王贤良,刘洪伟,毛静远,崔小磊.基于中国文化改良明尼苏达心力衰竭生存质量量表的测评[J].中国中西医结合杂志,2016(09).

邵正斌,戴小华,毛静远,付军,苏全,梁国庆,王时光.芪参益气滴丸对慢性心力衰竭患者心功能及超敏C-反应蛋白的影响[J].中国实验方剂学杂志,2015(15).

陈图刚,谭维羚,马战清,钟志英,孙国锋,周宇昕.芪参益气滴丸对慢性心力衰竭患者心功能和细胞因子的影响[J].中国老年学杂志,2011(05).

燕芳芳,刘艳,刘运芳,赵玉霞.芪参益气滴丸对实验性动脉粥样硬化超敏C反应蛋白的影响[J].上海中医药杂志,2007(02).

陈白玉,李熙芹,陈晓利.肿瘤坏死因子-α、白细胞介素-1β、-6水平与充血性心力衰竭关系的临床研究[J].临床内科杂志,2006(03).

Mao Jingyuan,Zhang Jian,Lam Carolyn S P,Zhu Mingjun,Yao Chen,Chen Shutao,Liu Zhongyong,Wang Fengrong,Wang Yonggang,Dai Xiaohua,Niu Tianfu,An Dongqing,Miao Yang,Xu Tao,Dong Bo,Ma Xiaofeng,Zhang Fengru,Wang Xiaolong,Fan Ruihong,Zhao Yingqiang,Jiang Tiemin,Zhang Yuhui,Wang Xianliang,Hou Yazhu,Zhao Zhiqiang,Su Quan,Zhang Junhua,Wang Baohe,Zhang Boli.Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial.[J].ESC heart failure,2020.

Department of Cardiology, University of Groningen, Groningen, The Netherlands.,Department of Cardiology, University of Groningen, Groningen, The Netherlands.,National Heart Centre Singapore, Singapore.,Department of cardiology, national heart center Singapore.,Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.,Corvidia Therapeutics, 35 Gatehouse Dr., Waltham, MA, USA.,Division of Cardiology and Metabolism - Heart Failure, Cachexia & Sarcopenia, Charité University Medicine, Berlin, Germany.,Department of Cardiology (CVK), Charité University Medicine, Berlin, Germany.,Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité University Medicine, Berlin, Germany.,Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Göttingen, Germany.,DZHK (German Center for Cardiovascular Research), University Medicine Göttingen (UMG), Göttingen, Germany.,National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, UK.,Stavanger University Hospital, University of Bergen, Stavanger, Norway.,School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.,Department of Cardiology, Heart Failure Unit, Athens University Hospital Attikon, Athens, Greece.,Department of Cardiology, University of Groningen, Groningen, The Netherlands.,Division of Molecular & Clinical Medicine, University of Dundee, Dundee, UK.,Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Institute of Cardiology, University of Brescia, Brescia, Italy.,Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester, Leicester, UK.,NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.,Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.,Poland and Cardiology Department, Military Hospital, Wroclaw, Poland.,Division of Molecular & Clinical Medicine, University of Dundee, Dundee, UK.,Inserm CIC 1433, Université de Lorrain, CHU de Nancy, Nancy, France.,Department of Epidemiology, Biostatistics & Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands.,Department of Cardiology, University of Groningen, Groningen, The Netherlands.,Department of Cardiology, University of Groningen, Groningen, The Netherlands.,Corvidia Therapeutics, 35 Gatehouse Dr., Waltham, MA, USA.,Department of Cardiology, University of Groningen, Groningen, The Netherlands.,Department of Cardiology, University of Groningen, Groningen, The Netherlands..The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.[J].European journal of heart failure,2019.

Velazquez Eric J,Morrow David A,DeVore Adam D,Duffy Carol I,Ambrosy Andrew P,McCague Kevin,Rocha Ricardo,Braunwald Eugene.Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.[J].The New England journal of medicine,2019.